Mississippi Retina Associates

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease3 trials
• Macular degeneration3 trials

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 1/21 trial
• Phase 2/31 trial
• Phase 41 trial

Status

• Completed4 trials
• Active, not recruiting3 trials

Lead sponsor

• Ocugen2 trials
• Aviceda Therapeutics, Inc.1 trial
• Greater Houston Retina Research1 trial
• McMaster University1 trial
• Oculis1 trial
• and 1 more

Running trials

• Active, not recruiting

  Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

  NCT06018558· Phase 1/2· Ocugen· Source

• Active, not recruiting

  A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

  NCT05956626· Phase 2/3· Ocugen· Source

• Active, not recruiting

  Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

  NCT05610319· Phase 4· McMaster University· Source

Closed trials

• Completed

  A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

  NCT06172257· Phase 3· Oculis· Source

• Completed

  Safety and Efficacy of Faricimab in Patients With NPDR

  NCT05681884· Phase 2· Greater Houston Retina Research· Source

• Completed

  A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

  NCT05839041· Phase 2· Aviceda Therapeutics, Inc.· Source

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Shanghai Henlius Biotech· Source